Dexamethasone Decreased Postoperative Complications in Tonsillotomy

Area of Science:

• Otolaryngology
• Pediatric Surgery
• Pharmacology

Background:

• Tonsillotomy (TT) is a prevalent surgical technique involving partial tonsil resection.
• Dexamethasone is frequently employed perioperatively for its anti-inflammatory, antiemetic, and analgesic effects.

Purpose of the Study:

• To investigate the impact of systemic steroid administration on postoperative outcomes following tonsillotomy.
• Specifically, to evaluate the effects on vomiting, pain, and bleeding in pediatric patients undergoing TT.

Main Methods:

• A randomized controlled trial was conducted with 240 children (ages 2-18) undergoing TT or adenotonsillotomy.
• Participants received either dexamethasone or a saline placebo prior to surgery.
• Postoperative hemorrhage, nausea, and vomiting were systematically recorded and compared between the two groups.

Main Results:

• The dexamethasone group showed significantly lower incidences of postoperative pain, nausea, and vomiting compared to the placebo group.
• Postoperative bleeding rates were comparable: 2.5% in the dexamethasone group versus 1.6% in the control group.
• No patients required reoperation for bleeding control in either group.

Conclusions:

• Systemic dexamethasone administration in tonsillotomy is safe, with no significant increase in postoperative bleeding.
• Dexamethasone effectively mitigates postoperative pain, nausea, and vomiting in pediatric patients undergoing tonsillotomy.